| pubmed-article:2022063 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C0032460 | lld:lifeskim |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C0032863 | lld:lifeskim |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C1167874 | lld:lifeskim |
| pubmed-article:2022063 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:2022063 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2022063 | pubmed:dateCreated | 1991-6-6 | lld:pubmed |
| pubmed-article:2022063 | pubmed:abstractText | The ability of several endocrine tests to distinguish between women with and without polycystic ovaries (PCO) has been studied prospectively in a series of 65 patients with functional oligo-amenorrhoea using ultrasonography as a reference test. In terms of overall diagnostic accuracy, the free androgen index (FAI) (94%) and the progestogen challenge (89%) gave similar results (Cl = -5 to 15%) but both were significantly better than all the other tests including measurement of serum LH (69%), total testosterone (71%) and androstenedione (74%) (minimum Cl = 6 to 23%). The FAI together with LH measurement was the most accurate of the combinations (97%) but this was not significantly better than the best of the combinations incorporating the progestogen challenge (92%; Cl = -3% to 13%). Given the limited availability of the assay for SHBG, these results show that assessment of oestrogen state is a useful method for categorizing patients with functional oligo-amenorrhoea. | lld:pubmed |
| pubmed-article:2022063 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2022063 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2022063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2022063 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2022063 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:2022063 | pubmed:issn | 0300-0664 | lld:pubmed |
| pubmed-article:2022063 | pubmed:author | pubmed-author:FoxRR | lld:pubmed |
| pubmed-article:2022063 | pubmed:author | pubmed-author:HullM GMG | lld:pubmed |
| pubmed-article:2022063 | pubmed:author | pubmed-author:CorriganEE | lld:pubmed |
| pubmed-article:2022063 | pubmed:author | pubmed-author:ThomasP APA | lld:pubmed |
| pubmed-article:2022063 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2022063 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:2022063 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2022063 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2022063 | pubmed:pagination | 127-31 | lld:pubmed |
| pubmed-article:2022063 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:meshHeading | pubmed-meshheading:2022063-... | lld:pubmed |
| pubmed-article:2022063 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2022063 | pubmed:articleTitle | The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. | lld:pubmed |
| pubmed-article:2022063 | pubmed:affiliation | University Department of Obstetrics and Gynaecology, Bristol Maternity Hospital, UK. | lld:pubmed |
| pubmed-article:2022063 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2022063 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2022063 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2022063 | lld:pubmed |
